Dr. Schutz is a board certified cardiologist and Fellow of the American College of Cardiology with over 35 years experience in clinical cardiology specializing in cardiac ultrasound. Prior to founding Sonivate Medical he developed cardiac electrical and radio-frequency sensor devices that resulted in successful medical technology start-up ventures. B.S., Phi Beta Kappa, and MD, University of Illinois. Cardiology Fellowship, former Assistant Professor of Medicine and Director of the Adult Echocardiography Laboratory, Oregon Health and Science University.
Lawrence Romel has over 25 years of drug development experience in clinical operations and project management for multiple therapeutic indications.
Mr. Romel is currently Sr. Vice President of Clinical Operations for Brickell Biotech and was previously Vice President of Clinical Operations at Cascadian Therapeutics. He was Chief Science Advisor and Vice President of Product Development for TranSenda International, a clinical operations software company where he was the main architect of their CTMS System. Prior to TranSenda, Mr. Romel served as Vice President of Clinical Operations and Project Management of Xcyte Therapies Inc., Supergen and Onyx Pharmaceuticals. His breadth of experience includes the clinical development of dermatologic drugs, biologics (GVAX), viral therapies (ONYX-015), toxin-sourced therapies (Ziconotide™), small molecule-based therapies (Tucatinib, Orathecin™, Decitabine), liposome encapsulated drug therapies (DOXIL™, Amphotec™), drug delivery devices and hospital/medical devices. He has managed Phase III development programs in both North America and Europe.
Mr. Romel holds a Master of Science degree in Chemistry from the University of Illinois, Chicago and is certified in Project Management through U.C. Berkeley.
JD William Mitchell College of Law, Masters of Business Management Hamline University, Undergrad Bemidji State University
Over 12 years in Healthcare Compliance. Most of that experience in house at Medical device and Pharma companies. Around 6 years of data privacy experience, including building out privacy programs, and leading a global GDPR readiness project.
Alex Ireland is Associate Director Business Development at Novotech, the leading Asia Pacific centered global biotech CRO. During her tenor, she has worked with 125+ biotech companies on 400+ studies in preparation for their upcoming Ph 1-3 clinical trials. Prior to joining Novotech, she worked for a small biotech company in a variety of business development and operational roles. Alex graduated from Boston University with a Master of Public Health.
Ike Ogbaa, MD is currently the US Medical Affairs Lead for New Products and Integrated Diabetes Care at Sanofi. His current role is to develop the US medical affairs strategy for Sanofi’s pipeline of New Diabetes Drugs, Devices and Digital health Solutions. He has extensive experience throughout the Pharmaceutical value chain in Clinical Pharmacology, Drug Development, Field-based Medical Affairs and Home-Office Medical affairs. He has worked for a CRO, small biotech and 2 large Pharma companies.
